Eyal C. Attar - May 8, 2023 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Chief Medical Officer
Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
VOR
Transactions as of
May 8, 2023
Transactions value $
-$4,012
Form type
4
Date filed
5/10/2023, 04:14 PM
Previous filing
Feb 8, 2023
Next filing
Aug 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Tax liability -$4.01K -969 -1.78% $4.14 53.5K May 8, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units ("RSUs").